NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation

[1]  A. Mastronuzzi,et al.  TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders , 2021, Blood advances.

[2]  D. Tenen,et al.  Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma , 2021, Stem cell reports.

[3]  W. Zuo,et al.  Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application , 2021, Clinical Immunology.

[4]  F. Locatelli,et al.  The role of interferon‐gamma and its signaling pathway in pediatric hematological disorders , 2021, Pediatric blood & cancer.

[5]  A. Gennery,et al.  Improved survival and graft function in ex vivo T-cell depleted haploidentical hematopoietic cell transplantation for primary immunodeficiency , 2020, Bone Marrow Transplantation.

[6]  Michael M. Henry,et al.  Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis. , 2020, The New England journal of medicine.

[7]  I. Caruana,et al.  Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation , 2019, Haematologica.

[8]  F. Locatelli,et al.  Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion. , 2017, Blood.

[9]  B. Gruhn,et al.  Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia , 2014, British journal of haematology.

[10]  Katia Perruccio,et al.  Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.